Site Overlay

Vietnam Veterans of America Issues Statement on the Department of Veteran Affairs’ VA Interim Final Rule – Evaluative Rating: Impact of Medication (RIN 2900-AS49)

(Washington, D.C.) — Vietnam Veterans of America (VVA) has carefully reviewed the Department of Veterans Affairs’ Interim Final Rule amending 38 C.F.R. § 4.10 regarding the evaluation of disabilities when medication is present. We have also reviewed VA’s official statement that this action formalizes a longstanding practice dating to 1958 and will not affect any veteran’s current disability rating.

This issue has generated significant concern across the veterans community. Much of that concern stems from uncertainty, uneven messaging, and the technical nature of the legal question involved. We believe it is important to separate emotion from policy and focus on facts.

This rule does not automatically reduce benefits. It does not reopen finalized ratings. It does not eliminate consideration of medication side effects. VA has stated clearly that current ratings will not be impacted.

At the same time, this regulatory clarification was issued without prior stakeholder engagement, which has understandably caused alarm. Veterans Service Organizations represent millions of veterans, and meaningful consultation before implementation of significant policy shifts strengthens trust, transparency, and system stability. That did not occur here, and that is a concern we respectfully raise.

The core policy question is whether disability compensation should be based on actual functional impairment as it exists with treatment, or on a theoretical estimate of how a condition would present without medication. Reasonable people can differ on that interpretation. What matters now is disciplined, consistent implementation.

Vietnam Veterans of America’s position is clear:

Ratings must reflect real-world functional loss, including breakthrough symptoms, flare-ups, and longitudinal patterns.
Medication side effects (fatigue, cognitive impairment, reliability limitations) must be documented and considered as part of actual impairment.
The statutory “benefit of the doubt” standard under 38 U.S.C. § 5107(b) must remain central in close cases.
VA must provide uniform guidance and training to prevent inconsistent application across regional offices.

We also recognize the broader system impact. If regulatory clarity reduces speculation and limits unnecessary remands, that may help move claims more efficiently for veterans currently waiting in the queue. Timely adjudication is itself a veterans’ rights issue.

Our request to VA and to Congress is measured and straightforward:

Engage formally with Veterans Service Organizations during the comment period before finalizing implementation guidance.
Issue clear examiner instructions addressing partial control, cyclical conditions, and sustained improvement standards.
Communicate directly and transparently with veterans to prevent misinformation and unnecessary fear.

This moment calls for steadiness, not panic nor politics. Veterans deserve a system that is fair, consistent, and stable. They also deserve to be heard before major regulatory clarifications are finalized.

Vietnam Veterans of America will continue to monitor implementation closely and advocate for guardrails that protect veterans while preserving system integrity.

Our responsibility is not to inflame, but to ensure that earned benefits are protected and that policy decisions are guided by fairness, law, and real-world impact.

Welcome to your local American Legion! We will no longer be open for dinner on Mondays and Tuesdays.

X